Entering text into the input field will update the search result below

Acura -6.4% AH after providing update for Aversion

May 27, 2014 5:52 PM ETAcura Pharmaceuticals, Inc. (ACUR) StockBy: Eric Jhonsa, SA News Editor
  • The FDA has advised Acura (OTCQB:ACUR) that data from its AP-ADF-301 intranasal abuse liability study for its Aversion combo drug is "insufficient to support an intranasal abuse deterrence claim."
  • Acura says its plans for the drug, including "a revised projected timeline" for submitting an NDA, will be determined following a meeting with the FDA.
  • The company adds it's "committed to developing [its] Aversion opiods products."

Recommended For You

More Trending News

About ACUR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ACUR--
Acura Pharmaceuticals, Inc.